Presence of Minor Anti Phospholipid Antibodies in Blood Samples of Ischemic Stroke Patients and Healthy Controls

Presence of Minor Anti Phospholipid Antibodies in Blood Samples of Ischemic Stroke Patients and Healthy Controls.

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01487746

Enrollment

207

Registered

2011-12-07

Start date

2011-12-31

Completion date

2012-09-30

Last updated

2011-12-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ischemic Stroke

Keywords

APLA, APS, Stroke, minor anti body, major anti body, APLA antibodies in Serum

Brief summary

The investigators expect to find higher levels of both classical and minor antiphospholipid (APL) antibodies among the stroke cases. Furthermore, the investigators expect to find not only classical APLA but also minor antibodies. The investigators believe that minor antibodies have a major role in the hypercoagulability state.

Interventions

None listed

Study design

Observational model

CASE_CONTROL

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Yes

Inclusion criteria

* stroke diagnosis * blood sampling within 36hrs from the event * written agreement

Exclusion criteria

* a stroke, MI or major operation prior to the current stroke * hypercoagulable state known in this patient * a severe chronic disease known at the time of the stroke * an infection on arrival (based on anamnesis, physical exam and lab tests) * thrombolytic treatment

Countries

Israel

Contacts

Primary ContactYair Levy, Prof.

levy.yair@clalit.org.il,0533671735

Backup ContactNarin N Carmel, B.Sc

carmeln@gmail.com0547691482

Outcome results